Processa Pharmaceuticals, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Notes Payable: Mandatory principal payments, loan payable (Tables)

Notes Payable: Mandatory principal payments, loan payable (Tables)

12 Months Ended

Dec. 31, 2013

Tables/Schedules

Mandatory principal payments, loan payable

Year ending December 31,	Payments
2014	$ 631,186
2015	44,001
2016	45,725
2017	37,361
2018	18,371
Total principal payments	776,644